HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Lawson Selected Research

gallium selenide

11/2019Facial emotion perception and social competence in children (8 to 16 years old) with genetic generalized epilepsy and temporal lobe epilepsy.
8/2018Theory of Mind and social competence in children and adolescents with genetic generalised epilepsy (GGE): Relationships to epilepsy severity and anti-epileptic drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Lawson Research Topics

Disease

3Inflammation (Inflammations)
01/2020 - 03/2004
3Atherosclerosis
07/2016 - 01/2008
2Epilepsy (Aura)
11/2019 - 08/2018
1Drug Resistant Epilepsy
01/2022
1COVID-19
10/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Generalized Epilepsy
11/2019
1Temporal Lobe Epilepsy
11/2019
1Tuberous Sclerosis (Bourneville's Disease)
11/2018
1Prostatic Neoplasms (Prostate Cancer)
01/2018
1Thrombosis (Thrombus)
07/2016
1Fever (Fevers)
07/2016
1Pain (Aches)
07/2016
1Migraine Disorders (Migraine)
01/2016
1Encephalitis (Encephalitis, Rasmussen)
08/2015
1Fibrosis (Cirrhosis)
04/2014
1Heart Diseases (Heart Disease)
04/2014
1Bronchiectasis
03/2014
1Abscess
01/2011
1Sepsis (Septicemia)
01/2011
1Headache (Headaches)
10/2009
1Hydrocephalus (Hydrocephaly)
10/2009
1Sensorineural Hearing Loss
10/2009
1Pneumonia (Pneumonitis)
05/2009
1Stroke (Strokes)
05/2006
1Myocardial Infarction
05/2006

Drug/Important Bio-Agent (IBA)

2gallium selenideIBA
11/2019 - 08/2018
2Dinoprostone (PGE2)FDA Link
07/2016 - 04/2014
2Epoprostenol (Prostacyclin)FDA LinkGeneric
07/2016 - 04/2014
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2016 - 04/2014
2ProstaglandinsIBA
07/2016 - 05/2006
1Biomarkers (Surrogate Marker)IBA
01/2021
1Amyloid beta-PeptidesIBA
01/2021
1C-Reactive ProteinIBA
01/2020
1Polytetrafluoroethylene (Teflon)FDA Link
11/2019
1Sirolimus (Rapamycin)FDA Link
11/2018
1EverolimusFDA Link
11/2018
1MTOR InhibitorsIBA
11/2018
1trans-sodium crocetinate (crocetin)IBA
11/2018
1Lamotrigine (Lamictal)FDA LinkGeneric
08/2018
1Ethosuximide (Zarontin)FDA LinkGeneric
08/2018
1Valproic Acid (Depakote)FDA LinkGeneric
08/2018
1Prostaglandin-E SynthasesIBA
07/2016
1LDL Receptors (LDL Receptor)IBA
07/2016
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2016
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2015
1N-Methylaspartate (NMDA)IBA
08/2015
1Laminin (Merosin)IBA
04/2014
1CollagenIBA
04/2014
1Pharmaceutical PreparationsIBA
04/2014
1EnzymesIBA
04/2014
1Indicators and Reagents (Reagents)IBA
03/2014
1Acyclovir (Aciclovir)FDA LinkGeneric
05/2009
1ApolipoproteinsIBA
01/2008
1Proteins (Proteins, Gene)FDA Link
01/2008
1Apolipoproteins E (ApoE)IBA
01/2008
1F2-Isoprostanes (F2 Isoprostanes)IBA
03/2004
1Oxidants (Oxidizing Agents)IBA
03/2004

Therapy/Procedure

2Therapeutics
01/2022 - 03/2014
1Personal Protective Equipment
10/2021
1Mechanical Ventilators (Ventilator)
10/2021
1Combination Drug Therapy (Combination Chemotherapy)
01/2018
1Analgesia
07/2016
1Catheters
01/2011
1Ventriculoperitoneal Shunt
10/2009